Skip to content

Umbilical Cord Milking in Neonates Who Are Depressed at Birth-Developmental Follow Up (MIDAB-FU)

Long-term Outcomes of Umbilical Cord Milking in Term and Late Preterm Neonates Who Are Depressed at Birth

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03681314
Acronym
MIDAB-FU
Enrollment
0
Registered
2018-09-24
Start date
2022-10-17
Completion date
2026-08-16
Last updated
2023-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Birth Asphyxia, Hypoxic-Ischemic Encephalopathy

Brief summary

An extension of the MIDAB trial, the MIDAB-Follow-up trial will evaluate the neurodevelopmental outcomes at 22-26 months age of term/late preterm infants who were depressed at birth and received umbilical cord milking (UCM) or immediate cord clamping (ICC).

Detailed description

The MIDAB-Follow-up trial will examine the difference in survival and neurodevelopmental impairment of infants who were depressed at birth and enrolled in MIDAB trial. The difference in survival and neurodevelopmental impairment in infants who received UCM and ICC will be assessed using standardized neurological and developmental assessment tools at 22-26 months of age.

Interventions

OTHERUmbilical Cord Milking

At delivery, the umbilical cord is grasped, and blood is pushed toward the infant 4 times before the cord is clamped. This procedure infuses a placental transfusion of blood into the infant and can be done in 10-15 seconds.

Sponsors

NPKSIMS, Nagpur, India
CollaboratorUNKNOWN
Sharp HealthCare
CollaboratorOTHER
Nemours Children's Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Masking description

Neurodevelopmental providers will be blinded to the randomization of the toddler during the examination.

Intervention model description

Neurodevelopmental assessments will be done at 2 years of age (22-26 months) for subjects who were randomized to receive either immediate cord clamping or umbilical cord milking as part of the MIDAB trial.

Eligibility

Sex/Gender
ALL
Age
3 Months to 26 Months
Healthy volunteers
No

Inclusion criteria

* Enrolled in MIDAB trial

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Neurodevelopmental Outcome at 2 Years of Age22-26 monthsOverall and Domain Scores - Ages and Stages, 3rd ed. Questionnaire

Secondary

MeasureTime frameDescription
Fidgety Movements at 3 months of age3-5 monthsAssessment of Fidgety Movements by Prechtl's method
Neurodevelopmental Outcome at 1 Year of Age10-14 monthsDevelopmental Activities Screening Inventory - Second Edition (DASI-II)
Autism Outcome22-26 monthsModified Checklist for Autism in Toddlers (M-CHAT-R)

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026